Cargando…
Aggravation of diabetes, and incompletely deficient insulin secretion in a case with type 1 diabetes‐resistant human leukocyte antigen DRB1*15:02 treated with nivolumab
Anti‐programmed cell death‐1 (PD‐1) antibody therapy induces various adverse effects, especially in the endocrine system. Several cases of acute‐onset insulin‐dependent diabetes after anti‐PD‐1 antibody therapy have been reported. Many of these cases have a susceptible human leukocyte antigen (HLA)...
Autores principales: | Matsumura, Kimio, Nagasawa, Kaoru, Oshima, Yoichi, Kikuno, Shouta, Hayashi, Kyohei, Nishimura, Akihiro, Okubo, Minoru, Uruga, Hironori, Kishi, Kazuma, Kobayashi, Tetsuro, Mori, Yasumichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835466/ https://www.ncbi.nlm.nih.gov/pubmed/28418115 http://dx.doi.org/10.1111/jdi.12679 |
Ejemplares similares
-
Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives
por: Nishimura, Akihiro, et al.
Publicado: (2019) -
Factors affecting glycemic control in diabetes mellitus complicated by autoimmune pancreatitis
por: Harai, Nozomi, et al.
Publicado: (2022) -
Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
por: Kato, Rina, et al.
Publicado: (2020) -
Next Generation Sequencing Reveals the Association of DRB3*02:02 With Type 1 Diabetes
por: Erlich, Henry A., et al.
Publicado: (2013) -
Transformation of epidermal growth factor receptor T790M mutation‐positive adenosquamous carcinoma of the lung to small cell carcinoma and large‐cell neuroendocrine carcinoma following osimertinib therapy: an autopsy case report
por: Moriguchi, Shuhei, et al.
Publicado: (2019)